| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |